Safety Study of AADC Gene Therapy (VY-AADC01) for Parkinson's Disease
a study on Parkinson's Disease
Parkinson's Disease PD Aromatic Amino Acid Decarboxylase AADC AAV2-AADC AAV2 Viral Vector Gene Therapy Gene Transfer MRI PET VY-AADC01 Parkinson Disease Dopa Decarboxylase VY-AADC01 Dose 1 VY-AADC01 Dose 2 VY-AADC01 Dose 3
Lead Scientist at UCSF
- Paul Larson
Dr. Paul Larson is Professor and Vice Chair of Neurological Surgery at the University of California San Francisco, Chief of Neurosurgery at the San Francisco VA Medical Center and Surgical Director of the Parkinson’s Disease Research, Education and Clinical Center. He specializes in functional neurosurgery, specifically deep brain stimulation for movement disorders and MR-guided procedures.